Olympus Labs

Olympus Labs

TBA
13,441 Views
We provide a web portal, SDKs, and APIs for financial product creators from both tech and non-tech backgrounds to easily create financial products for cryptocurrency investors.

Our protocol will create both tokenized and non-tokenized cryptocurrency financial products based on the specifications of the product creators. These financial products are available to investors through the Olympus APP as well as third-party wallets and applications that integrate the Olympus Protocol.
5.4
TOTAL SCORE
3.8
ICO PROFILE

(weight: 45%)

1
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
White paper: Read
Dates: TBA
Token info
Screenshots taken on 10 Jun 2018
HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Upcoming
ECTA
ECTA (Efficient Collaboration Team Autonomous) is the first blockchain-based trust protocol for global employability of developers. The concept, empowered by the proven AI tools, aims to solve the inefficiencies related to the time loss, verification of online profiles, talents discovery (especially in the low-middle income countries) and safe way to conduct business (payment solution with the power of smart contracts). While working on ECTA platform, besides collecting their earnings in ECTA tokens (ERC20) developers are having a unique possibility to earn (mine) ECTA non-fungible tokens (ERC721) as a reward for every task completed - which serve as proof of their skills and increase their reputation. AI component of the platform helps companies worldwide discover and employ these developers in a safe and productive way for both sides.
Upcoming
Fan360
The first sports community for fans, that covers the complete fan experience. Follow your favourite sports star, club or brand and get rewarded for engaging.
Upcoming
Xsure
Xsure is a decentralized risk management platform that facilitates real-time communication between insurance providers and the end customer. With the help of machine learning and blockchain trust-less governance technologies we have managed to eliminate third parties from the whole insurance life-cycle and turn it into a dynamic process instead of a static one.
Pre-Sale
2GETHER
2gether is developing the bank of the future, a future where; consumers take full ownership and control of the services they use, move beyond solely interacting with euros and dollars and fully embrace cryptocurrencies and digital assets, and augment their financial decisions through the use of exponential technologies like artificial intelligence, big data and blockchain. We are on a mission to change the way people interact with their finances. We are building a modern mutual organisation where everyone is an owner of their banking experience.
Upcoming
Innovasis Hotels
Blockchain Hotels will give the community of blockchain enthusiasts and digital nomands a great place to stay and a chance to capitalize on the current opportunities in the hospitality market. The business model employed by Blockchain Hotels allows our investors and guests to benefit from real estate profit-sharing as well as from the token model that is tradable on exchanges. Our system is designed to deliver both short and long term gains. The guest experience is designed to be entertaining, stimulating, and relaxing at the same time. The hotel facility and co-working spaces are designed to bring people together, and feature numerous attractions for guests to enjoy. Blockchain Hotels team prepared exclusive 4 video series where there is everything explained. Here you can watch it: http://bit.ly/videocampaign-blockchainhotels
Upcoming
MediLOT
MediLOT is a health data protocol that aims to solve the concerns of Electronic Health Records (EHR). Current EHR systems are fragmented, centralised and lack patient ownership. Through a dual blockchain solution, MediLOT incorporates Artificial Intelligence capabilities onboard its control and data layers which allows the equitable sharing of health data. The MediLOT ecosystem will consist of patients, healthcare providers, researchers and commercial companies.